Form D Explorer

Inspect source fieldsReport a record issue

Form D — Antigenix Therapeutics, Inc.

0002073993-25-000001 · filed Oct 24, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Other Health Care filings

Offering

Industry
Other Health Care
Exemptions
Rule 506(b)
Reported offering amount
$8,363,695
Reported amount sold
$3,363,695
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Antigenix Therapeutics, Inc.
CIK
2073993
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2024
Address
300 CARNEGIE CENTER, SUITE 150
PRINCETON, New Jersey 08540
Phone
(317) 552-5240

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗